If sufficient studies are available to investigate the cause of heterogeneity and its criteria, the following will be assessed: the types of stroke (e.g., ischemic or hemorrhagic), stroke duration (e.g., acute or chronic), the name of the herbal medicines used, and the formula of the herbal medicine (such as granules or decoctions).

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.